Active Ingredient (In Each Tablet)
Guaifenesin 200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Aphena Pharma Solutions - Tennessee, Llc for the product Mucus Relief (NDC 71610-098). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, keep out of reach of children, in case of pregnancy or breast feeding section, stop use and ask a doctor, directions:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 200 mg
Expectorant
ask a doctor before use if you have
In case of overdose, get medical help or contact a Poison Control Center right away.
ask a health professional before use
if cough lasts more than 7 days, comes back, or is accompanied by fever, rash or persistent headache.These could be signs of serious illness
colloidal silicon dioxide, FD&C RED#40(Al-lake), magnesium stearate, maltodextrin, microcrystalline cellulose, stearic acid, sodium starch glycolate
call 804-270-4498, 8.30 am-4.30 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
Please reference the How Supplied section listed above for a description of individual tablets. This drug product has been received by Aphena Pharma - TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
| Count | 200 mg |
| 3000 | 71610-098-18 |
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
* Please review the disclaimer below.